Coupons & Offers
Highlights
composition with strength
Minocycline (100mg)
description
A potent tetracycline antibiotic designed to treat severe acne and a wide range of bacterial infections. It effectively reduces inflammation and clears skin breakouts for long-lasting dermatological health.
key benefits
Treatment of Bacterial Infections and Acne
side effects
Dizziness , Photosensitivity , Vomiting , Nausea , Itching and Diarrhea
how to use
Take this medication as prescribed by your doctor. Swallow it whole—do not chew, crush, or break it.
pregnancy interaction
Unsafe
lactation interaction
Unsafe
driving interaction
Caution
kidney interaction
Caution
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Drogheria Sellers Private Limited
Seller Address
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
Pharmacy License No.
MH-MZ4-581161, MH-MZ4-581162
Manufacturer or Marketer Address
90, Delhi - Jaipur Road, Sector 32, Gurugram, Haryana 122001
Country of Origin
India
Manufacturer or Marketer Name
Sun Ranbaxy
Shelf Life
30 months
Expires on or after
November 2026
